Strategic Focus: ESG And Sustainability Digital Strategies For Healthcare

Join Vantage to access this research

Access our entire Corporate Sustainability Leaders research portfolio by joining Vantage

Need help or have a question about this report? Contact us for assistance

Executive Summary

Healthcare organizations – comprising healthcare and hospital services, medical device manufacturers and pharmaceutical firms – are under increasing pressure to integrate sustainability into their operations, while maintaining high standards around safety and patient care. From minimizing energy use in hospital systems to addressing the affordability of pharmaceutical products and medical devices, the healthcare sector faces unique challenges that demand innovative solutions. This report highlights strategies healthcare leaders can adopt to align their practices with global sustainability goals. 
Summary for decision-makers
Sustainable practices in healthcare protect people and the planet

Sustainability priorities in the healthcare industry
The healthcare sector faces numerous pressures and challenges – which were exacerbated by COVID-19
Healthcare firms must adopt processes and strategies to advance sustainability initiatives
Digital solutions can help healthcare firms embed sustainability into their business practices
Figure 1. Verdantix segmentation of the healthcare sector
Figure 2a. Healthcare and hospital services industry outlook
Figure 2b. Medical devices industry outlook
Figure 2c. Pharmaceutical products industry outlook
Figure 3. Representative material sustainability issues for the healthcare sub-sectors
Figure 4. Examples of sustainability initiatives in the healthcare industry
Figure 5. Internal building blocks for healthcare firms to advance their sustainability programmes  
Figure 6. Examples of industry groups helping firms with sustainability initiatives  
Figure 7. Examples of private-sector collaboration to improve sustainability performance
Figure 8. Six benefits of using digital solutions to support sustainability in the healthcare industry
AbbVie, AdvaMed, Aravo, Assent, Assist International, Association of the European Self-Medication Industry (AESGP), AstraZeneca, Baxter International, Bayer, Becton Dickinson and Company (BD), Benchmark Gensuite, Bio Farma, BioNTech, Boston Consulting Group (BCG), Boston Medical Center (BMC), Boston Scientific Corporation, Bristol Myers Squibb , Champalimaud Foundation, CommonSpirit Health, Compliance & Risks, CVS, Cytiva, Deloitte, DHL, Diversio, EcoVadis, Eli Lilly, Energize, Ethixbase360, European Federation of Pharmaceutical Industries and Associations (EFPIA), European Financial Reporting Advisory Group (EFRAG), EVA Pharma, GE Healthcare, Global Reporting Initiative (GRI), GSK, HCA Healthcare, Health Care at Home, Healthcare Anchor Network, International Committee of the Red Cross, International Hospital Federation (IHF), International Society for Pediatric and Adolescent Diabetes (ISPAD), Johnson & Johnson, Joint Commission International, Lilly, Mayo Clinic, Medical Society Consortium on Climate and Health, Medicines For Europe, Medtronic, Meiji, Merck KGaA, Moderna, Mölnlycke, NASDAQ, Nateria, National Health Service (NHS), NAVEX, Nortis, Novartis, Novisto, Novo Nordisk, Oritain, Persefoni, Pfizer, Pharmaceutical Research and Manufacturers of America (PhRMA), Pharmaceutical Supply Chain Initiative (PSCI), Philips, Purdue Pharma, Ramsay Health Care, Roche, Samsung Biologics, Sanofi, Schneider Electric, Serum Institute of India (SII), ServiceNow, Siemens Healthineers, Stryker, Sustainability Accounting Standards Board (SASB), Sustainable Healthcare Coalition, Sustainable Markets Initiative (SMI), Takeda Pharmaceuticals, Teva, Thermo Fisher Scientific, UN, UN Pan American Health Organization (PAHO), UNICEF, US Anesthesia Partners, VelocityEHS, Walmart, Workday, Workiva, World Diabetes Foundation (WDF), World Economic Forum, World Health Organization (WHO)

About the Authors

Jessica Pransky

Jessica Pransky

Principal Analyst

Jessica is a Principal Analyst at Verdantix, specializing in providing insights to sustainability leaders and analysing ESG and sustainability reporting software. She advises ...

View Profile
Elisa Molero

Elisa Molero

Senior Analyst

Elisa is a Senior Analyst at Verdantix, specializing in supply chain sustainability. Her research covers 100 vendors in the supply chain sustainability market, supporting buye...

View Profile
Kim Knickle

Kim Knickle

Research Director

Kim Knickle is a Research Director at Verdantix, bringing more than two decades of analyst experience to the evolving world of sustainability. Her current research spans ESG a...

View Profile

Other related content

Webinar
Corporate Sustainability Leaders
How To Prepare For Sustainability Repor...

Upcoming / 10 December, 2025

Blog
Corporate Sustainability Leaders
EUDR: Do European Regulators Have It Al...

The European Union Deforestation Regulation (EUDR) has been delayed again – this time just three months before its planned implementation in December 2025. This marks the second ye...

09 October, 2025

Blog
Corporate Sustainability Leaders
Navigating A Complex And Crowded Market...

The sustainability reporting and data management software landscape continues to evolve rapidly as firms adapt to regulatory uncertainty, rising stakeholder expectations and the ne...

03 October, 2025

Webinar
Corporate Sustainability Leaders
The Future Of EHS And Sustainability Le...

The role of the EHS and Sustainability leader has never been more complex — or more critical. No longer confined to compliance, today’s leaders must influence strategy, unite globa...

Upcoming / 06 November, 2025

Webinar
Corporate Energy Leaders
How To Break Down Walls In Building Dec...

Buildings account for over one-third of global energy-related carbon emissions, making them a critical focus for decarbonization. Yet for many organizations, the path forward feels...

Upcoming / 29 October, 2025

Webinar
Corporate Sustainability Leaders
Moving Goalposts: How To Prioritize You...

2025 shook sustainability to its core. Policy disruption, program cancellations, and fragmented strategies have left leaders facing the toughest Board conversations in years. As 20...

09 October, 2025